Anti-microbial vaccines

A couple vaccine programs with an evidence-based strategy for antimicrobial resistance, we must now move from blanket recommendations of vaccine use for antimicrobial resistance control to a pathogen-specific, vaccine-specific, and setting-specific quantification of vaccine policy. This crucial shift will rely on a new generation of mathematical models and of the economic frameworks in which these models will be embedded.

Target Audience :

Virology,  Anesthesiologists, Research Scholars, Nurse Practitioners,  Physicians, Business Entrepreneurs, Doctors, Surgeons, Healthcare professionals. Scientists, Researchers, Medical students, and Ph.D. fellows, Academicians, various Societies And Their Members, Pharmaceutical Devices Companies, Hospitals, Associations, and Societies.

Tags :

Corona conferences | Corona Conferences 2021 | Covid 19 | viruses | virology |Viral pathogenesis | Molecular virology |  Bacteriology |Pathology | Mycology | Rare diseases | Respiratory Viral Infections

Get In Touch


Via Amedeo Avogadro, 35, 00146 Roma RM, Italy

Call Us


Email Us

For Program Enquiry:
General Queries:
Abstract Deadline